Global Antibiotic Resistance Market: Overview
One of the largest threats to global health and development, antibiotic resistance can negatively impact an individual irrespective of age, gender, or race. Although the resistance to antibiotics is apparently a natural reaction, one of the key factors accelerating the prevalence is the increasing misuse and overuse of antibiotics. All countries need to utilize antibiotics in a responsible manner. For instance, ‘over the counter’ or OTC antibiotic use must be curbed if the resistance to antibiotics has to be mitigated.
Antimicrobial substances used to combat bacterial infection are known as antibiotics. Antibiotics are used to cure numerous medical conditions such as stroke, urinary tract infection (UTI), pneumonia, skin infections, ear infections, and several other disorders. Antibiotic resistance is when certain harmful bacteria grow resistant to antibiotic drugs that are utilized to treat the infections caused by them. While there are multiple antibiotic drugs in the pipeline, none of them are likely to be effective against some most dangerous kinds of antibiotic-resistant bacteria. Given the frequency and ease with which people from over the world now travel, antibiotic resistance is a global concern that requires collective effort from all countries and all quarters.
Global Antibiotic Resistance Market: Growth Factors
As a number of medical conditions including tuberculosis, pneumonia, salmonellosis, and gonorrhea are increasingly becoming difficult to treat due to diminished effectiveness of antibiotics, the global demand for antibiotic resistance is expected to shoot up over the upcoming years. The growing demand for generic drugs, increasing exposure to multi-drug resistant pathogens, and high burden of antibiotic-resistant infections are some drivers of global antibiotic resistance market. Moreover, antibiotic resistance has been posing a major challenge to the advancements of modern medicine. Chemotherapy, organ transplantations, and surgeries have become more perilous without effective antibiotics for preventing and treating infections.
Moreover, as the volume of investments in healthcare in general and in the area of antibiotic resistance is expanding across research institutes and universities, the global market for antibiotic resistance will witness a further boost. An upsurge in incidence of chronic and infectious diseases is also anticipated to drive the growth of global antibiotic resistance market. According to a 2018 report by WHO’s Global Antimicrobial Surveillance System (GLASS), the number of people with suspected bacterial infections was nearly half a million across 22 nations.
Global Antibiotic Resistance Market: Segmentation
Global antibiotic resistance market has been bifurcated by drug class, into tetracyclines, lipoglycopeptides, cephalosporins and others including sulfonamide. By pathogens, the global antibiotic resistance market can be broadly categorized into Streptococcus pneumonia, Acinetobacter, Hemophilus influenzae, Campylobacter, Clostridium difficile, Staphylococcus aureus and other including enterobacteriaceae. Clostridium difficile infections, complicated intra-abdominal infections, urinary tract infection (UTI), blood stream infections, acute bacterial skin infections, and others including gonorrhea & tuberculosis are some major segments based on disease. Hospitals &clinics, academic institutes, research organizations, and nursing homes are some major end-users.
Global Antibiotic Resistance Market: Regional Analysis
North America is anticipated to emerge as the largest market over the forthcoming years. Advancement of the pharmaceutical sector, increasing prevalence of infectious diseases, and increasing adoption of antibiotic resistance are the notable factors that are influencing the growth of North America antibiotic resistance market. Implementation of well-founded drug resistance surveillance programs in HIV and TB has helped calculate disease burden, plan treatment services, monitor the outcomes, and design better regimens to prevent future resistance to antibiotics.
Rising utilization of antibiotics, rise in bacterial infections, and high prevalence of infectious diseases are some key factors anticipated to drive the growth of antibiotic resistance market in Europe. In Germany, the number of patients suffering from hospital-acquired infections is continuously skyrocketing each year. This will induce a greater need for antibiotic resistance in the impending times.
Asia Pacific is the fastest developing regional market in antibiotic resistance owing to the surge in antibiotic-resistant infections and hospital-acquired infections. China is expected to dominate the global scenario due to the spiraling cases of multi-drug resistance. According to a report by WHO, in 2017, as many as 73,000 Chinese people developed multi-drug resistance to tuberculosis, being the second-highest number of antibiotic resistance cases in the world.
Global Antibiotic Resistance Market: Competitive Players
Some of the key manufacturers in the global antibiotic resistance market are Pzifer, Melinat Therapeutics, Allergan, Johnson & Johnson, Achaogen, Lupin, Teva, Achaogen, Merck, and Seres Therapeutics.
Global Antibiotic Resistance Market: Regional Segment Analysis
What Reports Provides